News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
725,956 Results
Type
Article (46777)
Company Profile (305)
Press Release (678873)
Multimedia
Podcasts (82)
Webinars (15)
Section
Business (209208)
Career Advice (2237)
Deals (36335)
Drug Delivery (108)
Drug Development (82717)
Employer Resources (177)
FDA (16416)
Job Trends (15282)
News (353343)
Policy (33301)
Tag
Academia (2594)
Accelerated approval (10)
Adcomms (27)
Allergies (96)
Alliances (51116)
ALS (116)
Alzheimer's disease (1472)
Antibody-drug conjugate (ADC) (166)
Approvals (16398)
Artificial intelligence (333)
Autoimmune disease (32)
Automation (19)
Bankruptcy (372)
Best Places to Work (11733)
BIOSECURE Act (20)
Biosimilars (125)
Biotechnology (223)
Bladder cancer (95)
Brain cancer (36)
Breast cancer (369)
Cancer (2953)
Cardiovascular disease (227)
Career advice (1859)
Career pathing (32)
CAR-T (199)
CDC (32)
Cell therapy (538)
Cervical cancer (22)
Clinical research (68044)
Collaboration (1075)
Company closure (3)
Compensation (690)
Complete response letters (28)
COVID-19 (2677)
CRISPR (64)
C-suite (344)
Cystic fibrosis (115)
Data (3039)
Decentralized trials (2)
Denatured (24)
Depression (69)
Diabetes (348)
Diagnostics (6494)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (144)
Drug pricing (129)
Drug shortages (28)
Duchenne muscular dystrophy (129)
Earnings (88369)
Editorial (43)
Employer branding (21)
Employer resources (154)
Events (117655)
Executive appointments (870)
FDA (18095)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (973)
Gene editing (141)
Generative AI (26)
Gene therapy (413)
GLP-1 (818)
Government (4559)
Grass and pollen (4)
Guidances (181)
Healthcare (18980)
HIV (41)
Huntington's disease (32)
IgA nephropathy (41)
Immunology and inflammation (164)
Immuno-oncology (11)
Indications (40)
Infectious disease (2854)
Inflammatory bowel disease (157)
Inflation Reduction Act (10)
Influenza (64)
Intellectual property (123)
Interviews (357)
IPO (16907)
IRA (46)
Job creations (3937)
Job search strategy (1592)
Kidney cancer (14)
Labor market (52)
Layoffs (519)
Leadership (22)
Legal (8139)
Liver cancer (79)
Longevity (12)
Lung cancer (405)
Lymphoma (212)
Machine learning (11)
Management (61)
Manufacturing (410)
MASH (91)
Medical device (13513)
Medtech (13518)
Mergers & acquisitions (20149)
Metabolic disorders (877)
Multiple sclerosis (100)
NASH (18)
Neurodegenerative disease (128)
Neuropsychiatric disorders (37)
Neuroscience (2183)
NextGen: Class of 2025 (6679)
Non-profit (4535)
Now hiring (48)
Obesity (444)
Opinion (263)
Ovarian cancer (102)
Pain (113)
Pancreatic cancer (123)
Parkinson's disease (190)
Partnered (23)
Patents (305)
Patient recruitment (169)
Peanut (51)
People (59410)
Pharmaceutical (69)
Pharmacy benefit managers (21)
Phase I (21303)
Phase II (30020)
Phase III (22216)
Pipeline (1674)
Policy (212)
Postmarket research (2587)
Preclinical (9073)
Press Release (72)
Prostate cancer (142)
Psychedelics (42)
Radiopharmaceuticals (258)
Rare diseases (495)
Real estate (6273)
Recruiting (68)
Regulatory (23138)
Reports (50)
Research institute (2381)
Resumes & cover letters (377)
Rett syndrome (10)
RNA editing (9)
RSV (51)
Schizophrenia (90)
Series A (169)
Series B (116)
Service/supplier (14)
Sickle cell disease (65)
Special edition (19)
Spinal muscular atrophy (150)
Sponsored (33)
Startups (3845)
State (2)
Stomach cancer (15)
Supply chain (78)
Tariffs (61)
The Weekly (56)
Vaccines (815)
Venture capital (58)
Weight loss (276)
Women's health (47)
Worklife (18)
Date
Today (96)
Last 7 days (380)
Last 30 days (1875)
Last 365 days (31897)
2025 (17271)
2024 (36004)
2023 (40707)
2022 (51899)
2021 (56368)
2020 (54689)
2019 (47153)
2018 (35599)
2017 (33139)
2016 (32595)
2015 (38465)
2014 (33845)
2013 (28963)
2012 (29450)
2011 (30119)
2010 (28199)
Location
Africa (803)
Alabama (62)
Alaska (7)
Arizona (247)
Arkansas (13)
Asia (40251)
Australia (6737)
California (7552)
Canada (2377)
China (696)
Colorado (324)
Connecticut (324)
Delaware (194)
Europe (87779)
Florida (1126)
Georgia (249)
Hawaii (1)
Idaho (59)
Illinois (667)
India (28)
Indiana (365)
Iowa (17)
Japan (233)
Kansas (113)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1043)
Massachusetts (5649)
Michigan (247)
Minnesota (463)
Mississippi (3)
Missouri (90)
Montana (31)
Nebraska (26)
Nevada (82)
New Hampshire (67)
New Jersey (2125)
New Mexico (29)
New York (2123)
North Carolina (1117)
North Dakota (9)
Northern California (3319)
Ohio (237)
Oklahoma (16)
Oregon (34)
Pennsylvania (1633)
Puerto Rico (17)
Rhode Island (36)
South America (1192)
South Carolina (34)
South Dakota (1)
Southern California (2819)
Tennessee (126)
Texas (1141)
United States (28077)
Utah (224)
Virginia (190)
Washington D.C. (72)
Washington State (647)
West Virginia (4)
Wisconsin (67)
725,956 Results for "edesa biotech inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results
May 15, 2025
·
10 min read
Press Releases
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
April 28, 2025
·
3 min read
Press Releases
Edesa Biotech Announces Chief Financial Officer Transition
April 7, 2025
·
4 min read
Edesa Biotech to Participate in Upcoming Investor Conferences
Edesa Biotech, Inc. announced today that Edesa management plans to participate in the following upcoming investor conferences.
April 2, 2024
·
3 min read
Press Releases
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results
February 17, 2025
·
9 min read
Business
Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results
Edesa Biotech, Inc. reported financial results for the three and six months ended March 31, 2024 and provided an update on its business.
May 10, 2024
·
11 min read
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
Edesa Biotech, Inc. announced today that the company will participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference scheduled for April 16-17, 2024 in Toronto, Ontario.
April 11, 2024
·
3 min read
Press Releases
Edesa Biotech Reports Fiscal Year 2024 Results
December 16, 2024
·
9 min read
BARDA Selects Edesa Biotech’s Drug for U.S. Funded Platform Trial in General ARDS
Edesa Biotech, Inc. announced today that its first-in-class drug candidate has been selected by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, for evaluation in a U.S. government-funded clinical study.
June 24, 2024
·
7 min read
Press Releases
Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
February 13, 2025
·
6 min read
1 of 72,596
Next
